OE33 In Vitro 8-isoprostane and iPF2α-VI Activity Assay (Oxidative Stress)

This assay is to provide OE33-based In Vitro 8-isoprostane and iPF2α-VI Activity Assay (Oxidative Stress) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

OE33

Human

The cell line OE33, also known as JROECL33, was established from the adenocarcinoma of the lower oesophagus (Barrett's metaplasia) of a 73 year old female patient. The tumour was identified as pathological stage IIA (UICC) and showed poor differentiation.

JROECL33

Esophageal Adenocarcinoma

Oncology

In Vitro 8-isoprostane and iPF2α-VI Activity Assay (Oxidative Stress)

OE33-cell based In Vitro 8-isoprostane and iPF2α-VI Activity Assay (Oxidative Stress)

Among isoprostanes, 8-isoprostane and iPF2α-VI have been considered as well-established markers for oxidative stress. A number of ELISA kits have been manufactured to determine 8-isoprostane and iPF2α-VI activity as an oxidative stress marker.

Oxidative Stress Assays

Disturbance between the production of reactive oxygen species (ROS), free radicals and antioxidant mechanisms is defined as the oxidative stress, or more precisely, it is an imbalance between the oxidant and antioxidant state in cells. This imbalance can cause harmful effects to cells and biomolecules, which ultimately causes adverse effects in the whole organism. Oxidative imbalance can target important proteinsand lipids in cells, which can increase the risk of developing a cancer. On the other hand, increased ROS production in cancer cells by certain cancer drugs can also arrest cancer cell cycle and cause senescence and apoptosis through oxidative stress.

Markers Thiobarbituric Acid Reactive Substances